The global Epilepsy Surgery Service market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
Epilepsy surgery is a type of neurosurgery that involves treating the parts of the brain that cause seizures. The operation is performed in order to lessen or eliminate the risk of seizures. The rise of the epilepsy surgery market can be ascribed to the rising incidence of neurological disorders, which has resulted in substantial research and development on epilepsy treatment devices, as well as an increase in the number of cases of brain injuries caused by car accidents.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report is a detailed and comprehensive analysis for global Epilepsy Surgery Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Epilepsy Surgery Service market size and forecasts, in consumption value ($ Million), 2020-2031
Global Epilepsy Surgery Service market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Epilepsy Surgery Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Epilepsy Surgery Service market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Epilepsy Surgery Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Epilepsy Surgery Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Duke Health, Nationwide Children's Hospital, NeuroPace, Chang Gung Medical Foundation, Emory Healthcare, Sidra Medicine, Aurora Health Care, Epilepsy Centers, UChicago Medicine, The Walton Centre, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
Epilepsy Surgery Service market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Resective Surgery
Laser Interstitial Thermal Therapy (LITT)
Others
麻豆原创 segment by Application
Hospitals and Clinics
Specialty Centers
麻豆原创 segment by players, this report covers
Duke Health
Nationwide Children's Hospital
NeuroPace
Chang Gung Medical Foundation
Emory Healthcare
Sidra Medicine
Aurora Health Care
Epilepsy Centers
UChicago Medicine
The Walton Centre
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Epilepsy Surgery Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Epilepsy Surgery Service, with revenue, gross margin, and global market share of Epilepsy Surgery Service from 2020 to 2025.
Chapter 3, the Epilepsy Surgery Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Epilepsy Surgery Service market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Epilepsy Surgery Service.
Chapter 13, to describe Epilepsy Surgery Service research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Epilepsy Surgery Service by Type
1.3.1 Overview: Global Epilepsy Surgery Service 麻豆原创 Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Epilepsy Surgery Service Consumption Value 麻豆原创 Share by Type in 2024
1.3.3 Resective Surgery
1.3.4 Laser Interstitial Thermal Therapy (LITT)
1.3.5 Others
1.4 Global Epilepsy Surgery Service 麻豆原创 by Application
1.4.1 Overview: Global Epilepsy Surgery Service 麻豆原创 Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospitals and Clinics
1.4.3 Specialty Centers
1.5 Global Epilepsy Surgery Service 麻豆原创 Size & Forecast
1.6 Global Epilepsy Surgery Service 麻豆原创 Size and Forecast by Region
1.6.1 Global Epilepsy Surgery Service 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Epilepsy Surgery Service 麻豆原创 Size by Region, (2020-2031)
1.6.3 North America Epilepsy Surgery Service 麻豆原创 Size and Prospect (2020-2031)
1.6.4 Europe Epilepsy Surgery Service 麻豆原创 Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Epilepsy Surgery Service 麻豆原创 Size and Prospect (2020-2031)
1.6.6 South America Epilepsy Surgery Service 麻豆原创 Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Epilepsy Surgery Service 麻豆原创 Size and Prospect (2020-2031)
2 Company Profiles
2.1 Duke Health
2.1.1 Duke Health Details
2.1.2 Duke Health Major Business
2.1.3 Duke Health Epilepsy Surgery Service Product and Solutions
2.1.4 Duke Health Epilepsy Surgery Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Duke Health Recent Developments and Future Plans
2.2 Nationwide Children's Hospital
2.2.1 Nationwide Children's Hospital Details
2.2.2 Nationwide Children's Hospital Major Business
2.2.3 Nationwide Children's Hospital Epilepsy Surgery Service Product and Solutions
2.2.4 Nationwide Children's Hospital Epilepsy Surgery Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Nationwide Children's Hospital Recent Developments and Future Plans
2.3 NeuroPace
2.3.1 NeuroPace Details
2.3.2 NeuroPace Major Business
2.3.3 NeuroPace Epilepsy Surgery Service Product and Solutions
2.3.4 NeuroPace Epilepsy Surgery Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 NeuroPace Recent Developments and Future Plans
2.4 Chang Gung Medical Foundation
2.4.1 Chang Gung Medical Foundation Details
2.4.2 Chang Gung Medical Foundation Major Business
2.4.3 Chang Gung Medical Foundation Epilepsy Surgery Service Product and Solutions
2.4.4 Chang Gung Medical Foundation Epilepsy Surgery Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Chang Gung Medical Foundation Recent Developments and Future Plans
2.5 Emory Healthcare
2.5.1 Emory Healthcare Details
2.5.2 Emory Healthcare Major Business
2.5.3 Emory Healthcare Epilepsy Surgery Service Product and Solutions
2.5.4 Emory Healthcare Epilepsy Surgery Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Emory Healthcare Recent Developments and Future Plans
2.6 Sidra Medicine
2.6.1 Sidra Medicine Details
2.6.2 Sidra Medicine Major Business
2.6.3 Sidra Medicine Epilepsy Surgery Service Product and Solutions
2.6.4 Sidra Medicine Epilepsy Surgery Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Sidra Medicine Recent Developments and Future Plans
2.7 Aurora Health Care
2.7.1 Aurora Health Care Details
2.7.2 Aurora Health Care Major Business
2.7.3 Aurora Health Care Epilepsy Surgery Service Product and Solutions
2.7.4 Aurora Health Care Epilepsy Surgery Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Aurora Health Care Recent Developments and Future Plans
2.8 Epilepsy Centers
2.8.1 Epilepsy Centers Details
2.8.2 Epilepsy Centers Major Business
2.8.3 Epilepsy Centers Epilepsy Surgery Service Product and Solutions
2.8.4 Epilepsy Centers Epilepsy Surgery Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Epilepsy Centers Recent Developments and Future Plans
2.9 UChicago Medicine
2.9.1 UChicago Medicine Details
2.9.2 UChicago Medicine Major Business
2.9.3 UChicago Medicine Epilepsy Surgery Service Product and Solutions
2.9.4 UChicago Medicine Epilepsy Surgery Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 UChicago Medicine Recent Developments and Future Plans
2.10 The Walton Centre
2.10.1 The Walton Centre Details
2.10.2 The Walton Centre Major Business
2.10.3 The Walton Centre Epilepsy Surgery Service Product and Solutions
2.10.4 The Walton Centre Epilepsy Surgery Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 The Walton Centre Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Epilepsy Surgery Service Revenue and Share by Players (2020-2025)
3.2 麻豆原创 Share Analysis (2024)
3.2.1 麻豆原创 Share of Epilepsy Surgery Service by Company Revenue
3.2.2 Top 3 Epilepsy Surgery Service Players 麻豆原创 Share in 2024
3.2.3 Top 6 Epilepsy Surgery Service Players 麻豆原创 Share in 2024
3.3 Epilepsy Surgery Service 麻豆原创: Overall Company Footprint Analysis
3.3.1 Epilepsy Surgery Service 麻豆原创: Region Footprint
3.3.2 Epilepsy Surgery Service 麻豆原创: Company Product Type Footprint
3.3.3 Epilepsy Surgery Service 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Epilepsy Surgery Service Consumption Value and 麻豆原创 Share by Type (2020-2025)
4.2 Global Epilepsy Surgery Service 麻豆原创 Forecast by Type (2026-2031)
5 麻豆原创 Size Segment by Application
5.1 Global Epilepsy Surgery Service Consumption Value 麻豆原创 Share by Application (2020-2025)
5.2 Global Epilepsy Surgery Service 麻豆原创 Forecast by Application (2026-2031)
6 North America
6.1 North America Epilepsy Surgery Service Consumption Value by Type (2020-2031)
6.2 North America Epilepsy Surgery Service 麻豆原创 Size by Application (2020-2031)
6.3 North America Epilepsy Surgery Service 麻豆原创 Size by Country
6.3.1 North America Epilepsy Surgery Service Consumption Value by Country (2020-2031)
6.3.2 United States Epilepsy Surgery Service 麻豆原创 Size and Forecast (2020-2031)
6.3.3 Canada Epilepsy Surgery Service 麻豆原创 Size and Forecast (2020-2031)
6.3.4 Mexico Epilepsy Surgery Service 麻豆原创 Size and Forecast (2020-2031)
7 Europe
7.1 Europe Epilepsy Surgery Service Consumption Value by Type (2020-2031)
7.2 Europe Epilepsy Surgery Service Consumption Value by Application (2020-2031)
7.3 Europe Epilepsy Surgery Service 麻豆原创 Size by Country
7.3.1 Europe Epilepsy Surgery Service Consumption Value by Country (2020-2031)
7.3.2 Germany Epilepsy Surgery Service 麻豆原创 Size and Forecast (2020-2031)
7.3.3 France Epilepsy Surgery Service 麻豆原创 Size and Forecast (2020-2031)
7.3.4 United Kingdom Epilepsy Surgery Service 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Russia Epilepsy Surgery Service 麻豆原创 Size and Forecast (2020-2031)
7.3.6 Italy Epilepsy Surgery Service 麻豆原创 Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Epilepsy Surgery Service Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Epilepsy Surgery Service Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Epilepsy Surgery Service 麻豆原创 Size by Region
8.3.1 Asia-Pacific Epilepsy Surgery Service Consumption Value by Region (2020-2031)
8.3.2 China Epilepsy Surgery Service 麻豆原创 Size and Forecast (2020-2031)
8.3.3 Japan Epilepsy Surgery Service 麻豆原创 Size and Forecast (2020-2031)
8.3.4 South Korea Epilepsy Surgery Service 麻豆原创 Size and Forecast (2020-2031)
8.3.5 India Epilepsy Surgery Service 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Southeast Asia Epilepsy Surgery Service 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Australia Epilepsy Surgery Service 麻豆原创 Size and Forecast (2020-2031)
9 South America
9.1 South America Epilepsy Surgery Service Consumption Value by Type (2020-2031)
9.2 South America Epilepsy Surgery Service Consumption Value by Application (2020-2031)
9.3 South America Epilepsy Surgery Service 麻豆原创 Size by Country
9.3.1 South America Epilepsy Surgery Service Consumption Value by Country (2020-2031)
9.3.2 Brazil Epilepsy Surgery Service 麻豆原创 Size and Forecast (2020-2031)
9.3.3 Argentina Epilepsy Surgery Service 麻豆原创 Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Epilepsy Surgery Service Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Epilepsy Surgery Service Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Epilepsy Surgery Service 麻豆原创 Size by Country
10.3.1 Middle East & Africa Epilepsy Surgery Service Consumption Value by Country (2020-2031)
10.3.2 Turkey Epilepsy Surgery Service 麻豆原创 Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Epilepsy Surgery Service 麻豆原创 Size and Forecast (2020-2031)
10.3.4 UAE Epilepsy Surgery Service 麻豆原创 Size and Forecast (2020-2031)
11 麻豆原创 Dynamics
11.1 Epilepsy Surgery Service 麻豆原创 Drivers
11.2 Epilepsy Surgery Service 麻豆原创 Restraints
11.3 Epilepsy Surgery Service Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Epilepsy Surgery Service Industry Chain
12.2 Epilepsy Surgery Service Upstream Analysis
12.3 Epilepsy Surgery Service Midstream Analysis
12.4 Epilepsy Surgery Service Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Duke Health
Nationwide Children's Hospital
NeuroPace
Chang Gung Medical Foundation
Emory Healthcare
Sidra Medicine
Aurora Health Care
Epilepsy Centers
UChicago Medicine
The Walton Centre
听
听
*If Applicable.